Punica granatum
Pomella®

What is Pomella?

Pomella® is a patented pomegranate extract standardized to deliver efficacious ellagitannins and metabolites, the major of which are punicalagins and their metabolites, urolithins. Pomella’s natural antioxidant properties support a number of applications such as cardio-metabolic support, healthy aging, skin and dermal support, and more.

Key Attributes:

Punica granatum extract

Protected by global intellectual property & multiple patents

Clinically researched for a multitude of tangible health applications

150-300mg / day

Standardized to punicalagins

Regulatory & Safety:

Excellent safety profile & published toxicology data

Non-GMO Project Verified / compliant

WADA (World Anti-Doping Agency) testing available*

Certified Glyphosate Residue Free

INCI Name: Punica granatum extract

Herbs of commerce volume 2

National Animal Supplement Council (NASC) approved / compliant

Meets or exceeds USP/ICH/Prop-65 standards

Self-GRAS affirmation

pomella-pomegranate-extract-logo-325x70

Pomella® pomegranate extract was developed to deliver efficacious ellagitannins, namely punicalagins, and their metabolites, urolithins. For many years, Pomella has been sold world-wide as a safe, efficacious, clinically supported pomegranate extract. Accredited by numerous universities, institutions, and certifying bodies globally, Pomella® is well-established with a long-standing history of exceeding global regulatory compliance, offering superior quality assurance and control parameters, as well as being supported by rigorous traceability and sustainability initiatives and clinical validation.

Exclusively offered by Verdure Sciences®, patented Pomella® delivers antioxidant benefits of punicalagins and urolithins to the blood and target tissues. This allows Pomella’s natural antioxidant benefits to be delivered at easily managed daily doses, promoting a wide range of tangible health benefits.

What is Pomella?

Pomella® pomegranate extract was developed to deliver efficacious ellagitannins, namely punicalagins, and their metabolites, urolithins. For many years, Pomella® has been sold world-wide as a safe, efficacious, clinically supported pomegranate extract. Accredited by numerous universities, institutions, and certifying bodies globally, Pomella® is well-established with a long-standing history of exceeding global regulatory compliance, offering superior quality assurance and control parameters, as well as being supported by rigorous traceability and sustainability initiatives and clinical validation.

Exclusively offered by Verdure Sciences®, patented Pomella® delivers antioxidant benefits of punicalagins and urolithins to the blood and target tissues. This allows Pomella’s natural antioxidant benefits to be delivered at easily managed daily doses, promoting a wide range of tangible health benefits.

Punica granatum extract

150-300mg  / day

Protected by global intellectual property & multiple patents

Clinically researched for a multitude of tangible health applications

Excellent safety profile & traditional use

Herbs of commerce volume 2

Non-GMO Project Verified / compliant

National Animal Supplement Council (NASC) approved / compliant

WADA (World Anti-Doping Agency) testing compliant

Meets or exceeds USP/ICH/Prop-65 standards

Certified Glyphosate Residue Free

Self-GRAS affirmation

INCI Name: Punica granatum extract

INGREDIENT RESEARCH

COMPETITIVE
ADVANTAGE

Strong ingredient development relies on validated, replicable testing methods and reference standards to ensure maximum activity and consistency. At Verdure, our research focuses on investigating and developing natural spectrum extracts that reflect a plant’s natural phytochemical profile, representative of the intrinsic synergies and applications used for a millennia.

verdure-sciences-research-tablet-bg-1920x540

Pomella Research

Strong ingredient development relies on validated, replicable testing methods and reference standards to ensure maximum activity and consistency. At Verdure, our research focuses on investigating and developing natural spectrum extracts that reflect a plant’s natural phytochemical profile, representative of the intrinsic synergies and applications used for a millennia.

verdure-sciences-scientist-testing-botanical-extract-1920x1080

Pomella Research

Strong ingredient development relies on validated, replicable testing methods and reference standards to ensure maximum activity and consistency. At Verdure, our research focuses on investigating and developing natural spectrum extracts that reflect a plant’s natural phytochemical profile, representative of the intrinsic synergies and applications used for a millennia.

New Research: Pomella® May Support Gut Microbiome, Short Chain Fatty Acids, And Impact Mitochondrial Health

January 2, 2024
A new four-week, double-blind, placebo-controlled, randomized clinical trial evaluated 250mg/day Pomella®, a proprietary Punica granatum extract, in healthy men and women 25-55yrs (n=18, predominantly women) for beneficial effects on the gut microbiome, circulating short-chain fatty acids, and gut-microbial derived ellagitannin metabolites, namely urolithins, using whole genome sequencing for gut microbial analysis.

New Research: Pomella® Pomegranate Extract Ellagitannins Further Proven To Convert To Urolithins; Polyphenol Capabilities

October 6, 2023
A new study with Pomella®, a proprietary Punica granatum extract, has evaluated bioavailability and absorption properties adding understanding to Pomella’s synergistic influence and polyphenol capabilities.

FDA Has No Objections To Pomella® GRAS Status

October 5, 2023
Verdure Sciences, Inc. has successfully achieved official Generally Recognized as Safe (GRAS) Status for the ingredient Pomella®, pomegranate extract after notification to the United States Food and Drug Administration (FDA), under the guidance of REJIMUS, INC., a preeminent regulatory consultancy to the Food, Beverage, and Dietary Supplement markets in the United States.

New Research: Pomella® May Support Gut Microbiome, Short Chain Fatty Acids, And Impact Mitochondrial Health

January 2, 2024
A new four-week, double-blind, placebo-controlled, randomized clinical trial evaluated 250mg/day Pomella®, a proprietary Punica granatum extract, in healthy men and women 25-55yrs (n=18, predominantly women) for beneficial effects on the gut microbiome, circulating short-chain fatty acids, and gut-microbial derived ellagitannin metabolites, namely urolithins, using whole genome sequencing for gut microbial analysis.

New Research: Pomella® Pomegranate Extract Ellagitannins Further Proven To Convert To Urolithins; Polyphenol Capabilities

October 6, 2023
A new study with Pomella®, a proprietary Punica granatum extract, has evaluated bioavailability and absorption properties adding understanding to Pomella’s synergistic influence and polyphenol capabilities.

FDA Has No Objections To Pomella® GRAS Status

October 5, 2023
Verdure Sciences, Inc. has successfully achieved official Generally Recognized as Safe (GRAS) Status for the ingredient Pomella®, pomegranate extract after notification to the United States Food and Drug Administration (FDA), under the guidance of REJIMUS, INC., a preeminent regulatory consultancy to the Food, Beverage, and Dietary Supplement markets in the United States.

New Research: Pomella® May Support Gut Microbiome, Short Chain Fatty Acids, And Impact Mitochondrial Health

January 2, 2024
A new four-week, double-blind, placebo-controlled, randomized clinical trial evaluated 250mg/day Pomella®, a proprietary Punica granatum extract, in healthy men and women 25-55yrs (n=18, predominantly women) for beneficial effects on the gut microbiome, circulating short-chain fatty acids, and gut-microbial derived ellagitannin metabolites, namely urolithins, using whole genome sequencing for gut microbial analysis.

New Research: Pomella® Pomegranate Extract Ellagitannins Further Proven To Convert To Urolithins; Polyphenol Capabilities

October 6, 2023
A new study with Pomella®, a proprietary Punica granatum extract, has evaluated bioavailability and absorption properties adding understanding to Pomella’s synergistic influence and polyphenol capabilities.

FDA Has No Objections To Pomella® GRAS Status

October 5, 2023
Verdure Sciences, Inc. has successfully achieved official Generally Recognized as Safe (GRAS) Status for the ingredient Pomella®, pomegranate extract after notification to the United States Food and Drug Administration (FDA), under the guidance of REJIMUS, INC., a preeminent regulatory consultancy to the Food, Beverage, and Dietary Supplement markets in the United States.